Abstract
IntroductionCoronary slow flow phenomenon (CSFP) is characterized by the delayed contrast filling of terminal vessels of coronary arteries in the presence of normal or nearly normal epicardial coronary arteries. Given that inflammation plays a role in cardiovascular disorders, including CSFP, using peripheral blood-derived compound prognostic indexes could be a feasible way to predict the presence of CSFP. Therefore, in the present study, we evaluated the association between pan-immune-inflammation value (PIV) and the CSFP. MethodsThis single-center, retrospective study was composed of 612 patients aged over 18 years who underwent CAG for suspected stable ischemic heart disease. The association of clinical and laboratory parameters with the CSFP was evaluated with univariate and multivariate analyses. ResultsThe median age of the patients was 54 (IQR 46–63) and 61.3% of the patients were male. The 12.6% (84/612) of the patients had CSFP, while the coronary flow was normal in the remaining 87.4% of patients. The PIV levels had moderate success for the prediction of the CSFP (AUC: 0.675, 95% CI: 0.615–0.735, p < 0.001). In multivariate analyses, male gender (OR: 4.858, 95% CI: 2.851–8.277, p < 0.001), presence of diabetes (OR: 2.672, 95% CI: 1.396–5.113, p = 0.003), lower HDL-C values (OR: 2.120, 95% CI: 1.286–3.496, p = 0.003), and higher PIV levels (OR: 2.527, 95% CI: 1.519–4.203, p < 0.001) were associated with a higher risk of CSFP. ConclusionWe demonstrated that a higher risk of CSFP in patients with PIV levels. If supported by prospective evidence, PIV levels could be used as a minimally invasive reflector of CSFP.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call